Cigna earnings beat by $0.04, revenue topped estimates
Brian W. Ellis, a director at Entergy Corp (NYSE:ETR), recently sold 647 shares of the company’s common stock. The transaction, which took place on May 30, 2025, was executed at a price of $82.32 per share, amounting to a total of $53,261. Following this sale, Ellis retains ownership of 11,298 shares in the company. The stock currently trades at $83.14, slightly above the insider’s sale price, with a market capitalization of $35.8 billion. According to InvestingPro data, Entergy has maintained dividend payments for 38 consecutive years, currently offering a 2.9% yield. The transaction was reported in a Form 4 filing with the Securities and Exchange Commission. InvestingPro analysis indicates the stock is currently fairly valued, with analysts setting a consensus high target of $105.72. For deeper insights into Entergy’s valuation and financial health metrics, including more exclusive ProTips, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Entergy Corporation reported its first-quarter earnings for 2025, highlighting a significant achievement in earnings per share (EPS) but a shortfall in revenue. The company posted an adjusted EPS of $0.82, surpassing the forecast of $0.69, while revenue was $3.02 billion, slightly below the anticipated $3.08 billion. Entergy also announced the settlement of forward sale agreements, delivering approximately 15.56 million shares of common stock, resulting in cash proceeds of about $806 million. This move is part of a larger equity distribution program. Entergy’s strategic focus on industrial sales showed strong growth, with a 9.3% increase, and the company maintains a positive outlook with a targeted EPS growth rate of over 8%. Analysts from firms like Guggenheim Partners and JPMorgan have shown interest in Entergy’s strategic direction, particularly regarding industrial sales and infrastructure investments. Additionally, Entergy’s ongoing financial management operations include remaining forward sale agreements for approximately 30.16 million shares, which could yield further proceeds. The company’s strategic initiatives, including a $37 billion capital plan through 2028, are expected to support long-term growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.